FDA NDC Directory · JSON-LD · Markdown

Aphexda

NDC 82737-073 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameMotixafortide
Labeler / ManufacturerBioLineRx USA Inc
Marketing categoryNew Drug Application (innovator) · App NDA217159
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsMOTIXAFORTIDE ACETATE (62 mg/1.7mL)
Marketing started20230908
Package count1

External sources

Source: openFDA. Public-domain (CC0).